Campbell introduces Encuity venture

Share this article:

Biopharma consultancy Campbell Alliance launched a market research and analytics group, one that could pose a threat to traditional MR firms.

The subsidiary, called Encuity Research, will be led by Campbell veteran Michael Turner.

It combines three components: SDI Health promotional and medical audit businesses that the consulting firm's parent, inVentiv Health, bought from IMS Health; service lines that came to Campbell after it was bought by inVentiv in 2011—RapidRecall (message effectiveness), Metropolitan Area Promotional Audit (syndicated audits of promotional activity), VisionCare (contact-lens market data), as well as a custom KOL mapping service; and Campbell's custom MR capability to support consulting projects.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?